Key stats
About Molecular Pharmacology (USA), Ltd.
Sector
CEO
Xin Shi
Headquarters
Stroudsburg
Founded
2002
FIGI
BBG000BVV030
Molecular Pharmacology (USA) Ltd. engages in the development of pharmaceutical products. It discovers and develops analgesic and anti-inflammatory products based on the proprietary MPL-TL compound. The MPL-TL compound is an oligopeptide which is a new key active ingredient that targets a different part of the pain and inflammation cascade than other analgesic and anti-inflammatory drugs. The company was founded on May 1, 2002 and is headquartered in Stroudsburg, PA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MLPH is 0.0006 USD — it hasn't changed in the past 24 hours. Watch Molecular Pharmacology (USA), Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Molecular Pharmacology (USA), Ltd. stocks are traded under the ticker MLPH.
MLPH reached its all-time high on Nov 9, 2005 with the price of 2.4500 USD, and its all-time low was 0.000001 USD and was reached on Aug 17, 2021. View more price dynamics on MLPH chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MLPH stock is 0% volatile and has beta coefficient of −50.26. Track Molecular Pharmacology (USA), Ltd. stock price on the chart and check out the list of the most volatile stocks — is Molecular Pharmacology (USA), Ltd. there?
No, MLPH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MLPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Molecular Pharmacology (USA), Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Molecular Pharmacology (USA), Ltd. technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Molecular Pharmacology (USA), Ltd. stock shows the buy signal. See more of Molecular Pharmacology (USA), Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.